Methotrexate use and liver disease--a causal relationship?
- PMID: 25066285
- PMCID: PMC4169390
- DOI: 10.1111/bjd.13103
Methotrexate use and liver disease--a causal relationship?
Comment on
-
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.Br J Dermatol. 2014 Jul;171(1):17-29. doi: 10.1111/bjd.12941. Epub 2014 Jul 15. Br J Dermatol. 2014. PMID: 24606161
References
-
- Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23(Suppl 2):1–70. - PubMed
-
- Nast A, Mrowietz U, Kragballe K, et al. National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines. Arch Dermatol Res. 2013;305:637–43. - PubMed
-
- Nast A, Reytan N, Rosumeck S, et al. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry. J Eur Acad Dermatol Venereol. 2008;22:1337–42. - PubMed
-
- Nast A, Mrowietz U, Kragballe K, et al. Barriers to the prescription of systemic therapies for moderate-to-severe psoriasis--a multinational cross-sectional study. Arch Dermatol Res. 2013 - PubMed
-
- Maybury CM, Jabbar-Lopez ZK, Wong T, et al. Methotrexate and liver fibrosis in people with psoriasis: A systematic review of observational studies. Br J Dermatol. 2014;10 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical